Sarepta Therapeutics (SRPT) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.71% |
| Dec 31, 2025 | -25.34% |
| Sep 30, 2025 | 8.11% |
| Jun 30, 2025 | 26.03% |
| Mar 31, 2025 | 18.89% |
| Dec 31, 2024 | 77.78% |
| Sep 30, 2024 | 59.75% |
| Jun 30, 2024 | 45.27% |
| Mar 31, 2024 | 34.86% |
| Dec 31, 2023 | 123.23% |
| Sep 30, 2023 | 77.41% |
| Jun 30, 2023 | 2.06% |
| Mar 31, 2023 | -16.82% |
| Dec 31, 2022 | -58.52% |
| Sep 30, 2022 | -8.24% |
| Jun 30, 2022 | 49.75% |
| Mar 31, 2022 | 60.03% |
| Dec 31, 2021 | 21.82% |
| Sep 30, 2021 | -47.37% |
| Jun 30, 2021 | -53.48% |
| Mar 31, 2021 | -53.23% |
| Dec 31, 2020 | -6.90% |
| Sep 30, 2020 | -10.37% |
| Jun 30, 2020 | -5.12% |
| Mar 31, 2020 | -15.11% |
| Dec 31, 2019 | -20.74% |
| Sep 30, 2019 | 55.54% |
| Jun 30, 2019 | 57.24% |
| Mar 31, 2019 | 73.61% |
| Dec 31, 2018 | 30.80% |
| Sep 30, 2018 | -8.22% |
| Jun 30, 2018 | 85.04% |
| Mar 31, 2018 | 81.00% |
| Dec 31, 2017 | 134.40% |
| Sep 30, 2017 | 70.61% |
| Jun 30, 2017 | 211.03% |
| Mar 31, 2017 | 208.82% |
| Dec 31, 2016 | 76.88% |
| Sep 30, 2016 | 231.58% |
| Jun 30, 2016 | -26.56% |
| Mar 31, 2016 | -30.78% |
| Dec 31, 2015 | -23.14% |
| Sep 30, 2015 | -56.94% |
| Jun 30, 2015 | -44.86% |
| Mar 31, 2015 | -12.32% |
| Dec 31, 2014 | 0.19% |
| Sep 30, 2014 | 15.88% |
| Jun 30, 2014 | 237.67% |
| Mar 31, 2014 | 162.33% |
| Dec 31, 2013 | 99.87% |
| Mar 31, 2013 | 522.46% |
| Dec 31, 2012 | 298.75% |
| Dec 31, 2011 | 1,201.06% |